# Clinical trials recruiting in Guatemala: 32 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 32 trials recruiting or not yet recruiting with a site in Guatemala, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Guatemala: 32 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/guatemala

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 32
- Recruiting or not yet: 32
- Read on: November 19, 2026

## Trials

The 25 newest of 32, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 29, 2026 | NCT07904767 | A Phase 2 Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis | Aperta Biosciences, LLC | Phase 2 | Not yet recruiting | Blepharitis | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904767) |
| September 4, 2026 | NCT07804667 | Pilot Study of a Modified Therapeutic Food Compared With a Standard Nutrient Supplement in Young Children in Rural Guatemala | Wuqu' Kawoq, Maya Health Alliance | Not applicable | Not yet recruiting | Stunting of Growth, Chronic Malnutrition | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804667) |
| June 8, 2026 | NCT07632014 | CAYA Cancer Prospective Cohort Study | Resonance, Inc. | Observational | Recruiting | Cancer, Pediatric Cancer, Lymphoblastic Lymphoma (LBL), Acute Lymphoblastic Leukemia (ALL) | 6,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07632014) |
| April 17, 2026 | NCT07536919 | Implementation Support for HEARTS-Based Hypertension and Diabetes Care in Guatemala | University of Michigan | Not applicable | Not yet recruiting | Hypertension (HTN), Type 2 Diabetes | 1,440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07536919) |
| February 3, 2026 | NCT07383428 | The INICIO-Guatemala Study | University of North Carolina, Chapel Hill | Not applicable | Recruiting | Development, Child | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07383428) |
| December 5, 2025 | NCT07266831 | A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) | Merck Sharp & Dohme LLC | Phase 2/3 | Recruiting | Human Immunodeficiency Virus Type 1 (HIV-1) Infection | 570 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07266831) |
| December 3, 2025 | NCT07262320 | Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America | University of Alabama at Birmingham | Observational | Recruiting | Dialysis, Critically Ill Acute Kidney Injury, Renal Replacement Therapy for Acute Kidney Injury in ICU, Acute Kidney... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07262320) |
| November 24, 2025 | NCT07246213 | CAYA Cancer Retrospective Cohort Study | Resonance, Inc. | Observational | Recruiting | Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Young Adult Cancer, Adolescent Cancer, Childhood Cancers, Acute... | 18,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07246213) |
| September 24, 2025 | NCT07190248 | A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Non-small Cell Lung Cancer | 675 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07190248) |
| May 13, 2025 | NCT06966700 | A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms | 2,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06966700) |
| April 13, 2025 | NCT06925737 | A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Prostate Cancer, Prostatic Neoplasms | 1,440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06925737) |
| March 3, 2025 | NCT06855108 | Caffeine for Hypoxic Ischemic Encephalopathy | NICHD Global Network for Women's and Children's Health | Phase 3 | Recruiting | Hypoxic Ischemic Encephalopathy (HIE) | 830 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06855108) |
| February 11, 2025 | NCT06819878 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately... | Hoffmann-La Roche | Phase 3 | Recruiting | Moderately to Severely Active Crohns Disease | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06819878) |
| December 30, 2024 | NCT06751836 | Innovative Multidisciplinary Strategies for Combating Severe Dengue | Karolinska Institutet | Observational | Recruiting | DENV Without Warning Signs, DENV with Warning Signs, Severe Dengue, Healthy Controls Group - Age and Sex-matched | 1,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06751836) |
| December 27, 2024 | NCT06750120 | Addressing the Double Burden of Malnutrition in Guatemala | Brigham and Women's Hospital | Not applicable | Recruiting | Maternal Obesity Complicating Pregnancy, Birth,or Puerperium, Child Malnutrition | 1,532 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06750120) |
| December 9, 2024 | NCT06723392 | Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries | NICHD Global Network for Women's and Children's Health | Phase 3 | Recruiting | Preterm Birth, Small for Gestational Age (SGA), Stillbirth, Bacteriuria (Asymptomatic) in Pregnancy | 1,134 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06723392) |
| December 5, 2024 | NCT06717347 | A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP)... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Diffuse Large B-Cell Lymphoma | 1,046 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06717347) |
| December 2, 2024 | NCT06711887 | Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus... | Novartis Pharmaceuticals | Phase 3 | Recruiting | Lupus Nephritis | 348 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06711887) |
| August 22, 2024 | NCT06565559 | EMUs: Enhanced Monitoring Using Sensors After Surgery | University of Edinburgh | Observational | Recruiting | Surgery, Inpatients | 1,332 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06565559) |
| March 18, 2024 | NCT06314282 | INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use | AstraZeneca | Observational | Recruiting | Systemic Lupus Erythematosus (SLE) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06314282) |
| November 18, 2023 | NCT06136650 | A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms | 1,314 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06136650) |
| November 18, 2023 | NCT06133972 | Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). | Novartis Pharmaceuticals | Phase 3 | Recruiting | Systemic Lupus Erythematosus | 550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06133972) |
| July 5, 2023 | NCT05929976 | InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort | Columbia University | Observational | Recruiting | Acute Lymphoblastic Leukemia, Nutrition Aspect of Cancer, Microtia, Genetic Predisposition | 4,900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05929976) |
| October 4, 2022 | NCT05566431 | Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics | University of Washington | Not applicable | Recruiting | Severe Traumatic Brain Injury | 428 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05566431) |
| September 30, 2022 | NCT05562466 | A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less... | Novartis Pharmaceuticals | Phase 3 | Recruiting | Asthma | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05562466) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Unidad Nacional de Oncología Pediátrica (UNOP) | Guatemala City | 2 |
| Hospital General San Juan de Dios | Guatemala City | 2 |
| INTEGRA Cancer Institute-Oncology | Guatemala City | 1 |
| Instituto Guatemalteco de Seguridad Social | Guatemala City | 1 |
| Cen Integral Onco Gastro y Hemato Onco Guatemala S.A. | Guatemala City | 1 |
| Unidad Nacional De Oncologia Pediatrica | Guatemala City | 1 |
| Fundacion para la Salud Integral de los Guatemaltecos | Coatepeque | 1 |
| Hospital Regional de Esquintla | Escuintla | 1 |
| Hospital Regional de Occidente San Juan de Dios | Quetzaltenango | 1 |
| Celan S.A. | Guatemala City | 1 |
| Centro Integral De Oncologia Gastrointestinal Y Hemato-Oncologia De Guatemala, S. A | Guatemala City | 1 |
| Institute of Nutrition of Central America And Panama (INCAP) | Chimaltenango | 1 |
| Grupo Medico Angeles | Guatemala City | 1 |
| Institue for Nutrition of Central America and Panama (INCAP) | Guatemala City | 1 |
| INTEGRA Cancer Institute | Guatemala City | 1 |
| Onco Go, S.A | Guatemala City | 1 |
| Institute for Nutrition of Central America and Panama (INCAP) | Guatemala City | 1 |
| Med Clinic | Guatemala City | 1 |
| Ministry of Health health centers | Guatemala City | 1 |
| Hospital de Día, Clínica de Ojos Doctor Gutiérrez | Guatemala City | 1 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2 | 3 |
| Phase 2/3 | 2 |
| Phase 3 | 12 |
| Phase 4 | 1 |
| Not applicable | 5 |
| Observational | 9 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Prostatic Neoplasms | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Neoplasms | 2 |
| Asthma | 2 |
| Autoimmune Diseases | 2 |
| Stillbirth | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Acute Kidney Injury | 1 |
| Severe Dengue | 1 |
| Infections | 1 |
| Inflammation | 1 |
| Congenital Microtia | 1 |
| Genetic Predisposition to Disease | 1 |
| Brain Injuries, Traumatic | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Hypoxia-Ischemia, Brain | 1 |
| Lupus Nephritis | 1 |
| Hematologic Neoplasms | 1 |
| Premature Birth | 1 |
| Bacteriuria | 1 |
| Breast Neoplasms | 1 |
| Triple Negative Breast Neoplasms | 1 |
| Parkinson Disease 4, Autosomal Dominant Lewy Body | 1 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 9 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 5 |
| NICHD Global Network for Women's and Children's Health | 3 |
| Resonance, Inc. | 2 |
| University of Alabama at Birmingham | 1 |
| University of Edinburgh | 1 |
| Karolinska Institutet | 1 |
| Columbia University | 1 |
| University of North Carolina, Chapel Hill | 1 |
| University of Washington | 1 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 1 |
| Wuqu' Kawoq, Maya Health Alliance | 1 |
| Brigham and Women's Hospital | 1 |
| University of Michigan | 1 |
| [Bayer](https://specstream.ai/data/clinical-trials/company/bayer) | 1 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 1 |
| Aperta Biosciences, LLC | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Beach resorts in the United States](https://specstream.ai/data/businesses/beach-resorts/united-states)
- [Afghani restaurants in the United States](https://specstream.ai/data/businesses/afghani-restaurants/united-states)
- [Tenant and eviction law firms in the United States](https://specstream.ai/data/businesses/tenant-and-eviction-law-firms/united-states)
- [Records storage companies in the United States](https://specstream.ai/data/businesses/records-storage-companies/united-states)
- [Otology practices in the United States](https://specstream.ai/data/businesses/otology-practices/united-states)
- [Latin American restaurants in the United States](https://specstream.ai/data/businesses/latin-american-restaurants/united-states)
